Home > Issue Outline

September 04, 2008

Volume 8, Issue 17

Browse Issues

• At the Meetings

  • • At the Meetings
    New Therapies in the Pipeline for AD — What's Promising, What's Not
  • • At the Meetings
    National ‘Think Tank’ Calls for New Vision for Neuroscience
  • • At the Meetings
    Meeting Planner

• For Your Patients

  • • For Your Patients
    Motor Neurons Made from ALS Skin Fibroblasts
  • • For Your Patients
    Fampridine May Improve Walking Ability in Some MS Patients
  • • For Your Patients
    Three Years Post-Katrina, An Institution Strives for Renewal
  • • For Your Patients
    UK Pregnancy Study Finds Slight Increase in Birth Defects with Topiramate
  • • For Your Patients
    The Patients, The Techniques
  • • For Your Patients
    Heme Gene Controller May Be a New Path To Treatment of Parkinson Disease
  • • For Your Patients
    Two More Patients on Natalizumab Develop PML
  • • For Your Patients
    The Abigail Alliance Case: A Different Legal Challenge
  • • For Your Patients
    The Neuroscience Behind Sports

• Best Advances

  • • Best Advances
    New Methods for Detecting and Deciphering Types of Traumatic Brain Injury

• Policy and Practice

  • • Policy and Practice
    Contract Law and Ethical Issues Underscore the Latest Lawsuit About Access to Experimental Drugs for Duchenne Muscular Dystrophy
  • • Policy and Practice
    Neurologists Challenge Insurers' Flawed ‘Tiering’ Systems: Seeking Input and Transparency

Issue Cover

Editor's Pick Podcast

Back to Top